URL details: kartosthera.com/research
URL title:
Research | Kartos Therapeutics
URL description:
Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232
URL last crawled:
2022-09-12
URL speed:
0.149 MB/s,
downloaded in 0.100 seconds
We found no external links pointing to this url.